Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,190,206 papers from all fields of science
Search
Sign In
Create Free Account
E 5531
Known as:
E-5531
, E5531
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Lipid A
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Innate immune-stimulatory activity of Porphyromonas gingivalis fimbriae is eliminated by phase separation using Triton X-114.
Kohji Nozoe
,
T. Sanui
,
+4 authors
F. Nishimura
JIM - Journal of Immunological Methods
2017
Corpus ID: 4051737
2007
2007
The cellular Toll-like receptor 4 antagonist E5531 can act as an agonist in horse whole blood.
C. Bryant
,
Andre J. Ouellette
,
+4 authors
Belinda A. Farnfield
Veterinary Immunology and Immunopathology
2007
Corpus ID: 24163634
Highly Cited
2001
Highly Cited
2001
A Novel Synthetic Acyclic Lipid A-like Agonist Activates Cells via the Lipopolysaccharide/Toll-like Receptor 4 Signaling Pathway*
E. Lien
,
Jesse C. Chow
,
+5 authors
D. Golenbock
Journal of Biological Chemistry
2001
Corpus ID: 20980449
ER-112022 is a novel acyclic synthetic lipid A analog that contains six symmetrically organized fatty acids on a noncarbohydrate…
Expand
2000
2000
The Effect of Divalent Cations on the Membrane Properties and Pharmacokinetics in Rat of the Lipid A Analogue E5531
Y. Asai
,
Y. Sano
,
K. Kikuchi
,
K. Iwamoto
,
Sumio Watanabe
The Journal of pharmacy and pharmacology
2000
Corpus ID: 1327371
To obtain information on the effects of Ca2+ on the membrane properties of the lipid A analogue E5531, we have determined the…
Expand
1999
1999
The effect of the lipid A analog, E5531 on fever induced by endotoxin from Escherichia coli.
Y. Asai
,
Y. Nozu
,
T. Ikeuchi
,
R. Narazaki
,
K. Iwamoto
,
S. Watanabe
Biological and Pharmaceutical Bulletin
1999
Corpus ID: 28301822
E5531 is a specific lipid A antagonist and is expected to be a drug for the treatment of septic shock. The LAL (limulus amebocyte…
Expand
1999
1999
Control of the Dispersing Process and Pharmacokinetics in Rats for Lipid A Analogue, E5531
Y. Asai
,
Y. Sano
,
K. Kikuchi
,
K. Iwamoto
,
S. Watanabe
The Journal of pharmacy and pharmacology
1999
Corpus ID: 24360672
E5531 is a synthetic disaccharide analogue of lipid A which has a low toxicity but retains the ability to reduce production of…
Expand
1998
1998
The effect of the lipid A analog E5531 on phospholipid membrane properties
Y. Asai
,
K. Iwamoto
,
Sumio Watanabe
FEBS Letters
1998
Corpus ID: 603011
Review
1998
Review
1998
[Sepsis and organ failure--its pathogenesis and treatment].
K. Hanasawa
,
M. Kodama
Nihon Geka Gakkai zasshi
1998
Corpus ID: 24348609
Sepsis, septic shock, and multiple organ dysfunction are heterogeneous and sophisticated clinical syndromes which result from the…
Expand
1995
1995
E5531, AN ENDOTOXIN ANTAGONIST, BLOCKS THE HYPERDYNAMIC AND DEPRESSANT CARDIOVASCULAR EFFECTS OF ENDOTOXIN IN HEALTHY SUBJECTS
E. Bunnell
,
A. Neumann
,
+4 authors
J. Parrillo
1995
Corpus ID: 76355593
1995
1995
EFFECT OF E5531 ON SYSTEMIC RESPONSES TO ENDOTOXIN IN HEALTHY VOLUNTEERS
E. Bunnell
,
M. Lynn
,
J. Parrillo
,
Kalim J. Habet
,
L. Friedhoff
,
S. Rogers
1995
Corpus ID: 75594540
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE